Enzychem Lifesciences Corporation (KOSDAQ:A183490) announced a private placement of series 2 unregistered coupon nonguaranteed private convertible bond for an aggregate gross proceeds of KRW 50,000,000,000 on November 4, 2020. The transaction will include participation from Suseong KOSDAQ Venture M4 Hedge Fund and Suseong KOSDAQ Venture M2 Hedge Fund for KRW 2,000,000,000, Suseong Kosdaq Venture M6 Hedge Fund for KRW 1,000,000,000, Hyundai Mezzanine Hedge Fund2, Hyundai MJ Kosdaq Venture Hedge Fund1, and Hyundai MJ Kosdaq Venture Hedge Fund2 for KRW 2,000,000,000, Atman KOSDAQ Venture Hedge Fund 1 for KRW 1,000,000,000, Darum IPO KOSDAQ Venture Hedge Fund 1 for KRW 500,000,000, GV Mezz-V2 Hedge Fund for KRW 1,000,000,000, Reun Kosdaq Venture Hedge Fund4 for KRW 500,000,000, Astra KOSDAQ Venture Hedge Fund 6 for KRW 1,000,000,000, Lee Hyun KOSDAQ Venture Hedge Fund1 for KRW 1,000,000,000, SP Mezzanine Hedge Fund6 for KRW 2,000,000,000, Orian Mezzanine Multi-Strategy Hedge Fund1 and Orian Mezzanine KOSDAQ Venture Hedge Fund 48 for KRW 1,300,000,000, Orion KOSDAQ Venture Hedge Fund 28 and Orian KOSDAQ Venture Hedge Fund 40, Orian Growth-Multi KOSDAQ Venture Hedge Fund 42, Orian General Manager Plus KOSDAQ Venture Hedge Fund 45 arc for KRW 2,700,000,000, Asam Mezzanine Plus Hedge Fund 1 and Assem KOSDAQ Venture Plus Hedge Fund 6 for KRW 1,000,000,000, Assem Dunden KOSDAQ Venture Hedge Fund 1 for KRW 500,000,000, Anda H KOSDAQ Venture Investment Investment Trust No. 1, Anda H KOSDAQ Venture Hedge Fund2, and Anda H KOSDAQ Venture Hedge FundA for KRW 9,000,000,000, Anda Planet Hedge Fund1 for KRW 500,000,000, Tiger KOSDAQ Venture Fund POTENTIAL 107 Hedge Fund, Tiger KOSDAQ Venture Fund STEWARD 108 Hedge Fund for KRW 1,400,000,000, Tiger Mezzanine Hama 001 Hedge Fund, Tiger Mezzanine & Alpha 202 Hedge Fund, Tiger Alpha 203 Hedge Fund, Tiger Metes 204 Hedge Fund, Tiger KOSDAQ Venture Fund ALPHA 2 Hedge Fund for KRW 2,600,000,000, CS Advisors Co., Ltd. for KRW 1,000,000,000, Mirae Asset Daewoo Co., Ltd., Investment Arm for KRW 2,000,000,000, Kiwoom Securities Co., Ltd., Investment Arm for KRW 2,000,000,000, Hanyang Securities Co., Ltd., Investment Arm for KRW 2,500,000,000, DB Financial Investment Co.,Ltd., Investment Arm for KRW 1,000,000,000, and Cave-Brain KOSDAQ Scale-up New Technology Business Fund for KRW 10,500,000,000. The bonds shall mature on November 6, 2025. The bonds carry zero coupon rate. The bonds are fully convertible into 499,021 shares of the company at a conversion price of KRW 100,196 per share. The conversion period will start from November 06, 2021 and ends on October 6, 2025. The transaction is expected to close on November 6, 2020. The transaction has been approved by the board of directors of the company.